Mckesson (MCK) Cash & Equivalents (2009 - 2026)
Mckesson (MCK) posted quarterly Cash & Equivalents of $4.0 billion for Q1 2026, down 30.15% year-over-year from $5.7 billion in Q1 2025, and up 34.34% quarter-over-quarter from $3.0 billion in Q4 2025.
Mckesson (MCK) Cash & Equivalents (2009 - 2026) Analysis & Trends
Mckesson (MCK) has reported Cash & Equivalents for 18 consecutive years, with $4.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents fell 30.15% year-over-year to $4.0 billion; the TTM figure through Mar 2026 stood at $4.0 billion (down 30.15% YoY), while the FY2026 annual figure was $4.0 billion, down 30.15% from the prior year.
- Cash & Equivalents advanced to $4.0 billion in Q1 2026 per MCK's latest filing, from $3.0 billion in the prior quarter.
- Across five years, Cash & Equivalents topped out at $5.7 billion in Q1 2025 and bottomed at $1.1 billion in Q4 2024.
- Historically, Cash & Equivalents has averaged $3.1 billion across 5 years, with a median of $2.8 billion in 2022.
- Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 43.74% — and 2025, when it jumped 161.63%.
- Mckesson's Cash & Equivalents stood at $2.8 billion in 2022, then dropped by 28.55% to $2.0 billion in 2023, then tumbled by 42.94% to $1.1 billion in 2024, then surged by 161.63% to $3.0 billion in 2025, then soared by 34.34% to $4.0 billion in 2026.
- Business Quant data shows MCK's Cash & Equivalents at $4.0 billion in Q1 2026, $3.0 billion in Q4 2025, and $4.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 5.16 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 2.82 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 4.86 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 157.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | 200,000.00 |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 21.54 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 7.65 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 54.59 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 1.80 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.16 Bn |
| Mar 31, 2026 | 3.98 Bn |
| Dec 31, 2025 | 2.96 Bn |
| Sep 30, 2025 | 4.00 Bn |
| Jun 30, 2025 | 2.42 Bn |
| Mar 31, 2025 | 5.69 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 2.51 Bn |
| Jun 30, 2024 | 2.30 Bn |
| Mar 31, 2024 | 4.58 Bn |
| Dec 31, 2023 | 1.98 Bn |
| Sep 30, 2023 | 2.52 Bn |
| Jun 30, 2023 | 2.64 Bn |
| Mar 31, 2023 | 4.68 Bn |
| Dec 31, 2022 | 2.77 Bn |
| Sep 30, 2022 | 2.92 Bn |
| Jun 30, 2022 | 2.23 Bn |
| Mar 31, 2022 | 3.53 Bn |
| Dec 31, 2021 | 2.75 Bn |
| Sep 30, 2021 | 2.15 Bn |